Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Verweij

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The Pharmacogenomics Journal|March 5, 2014
Gene expression analysis in RA: towards personalized medicineA N Burska, K Roget, M Blits, et al.
Genes and Immunity|November 9, 2002
Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphismT C T M van der Pouw Kraan, M Küçükaycan, A M Bakker, et al.
Molecular Medicine (Cambridge, Mass.)|February 5, 1999
Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritisE L Kaijzel, M V van Krugten, B M Brinkman, et al.
Genes and Immunity|October 12, 2007
Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patientsT C T M van der Pouw Kraan, L G M van Baarsen, C A Wijbrandts, et al.
Genes and Immunity|February 24, 2001
An IL-13 promoter polymorphism associated with increased risk of allergic asthmaT C van der Pouw Kraan, A van Veen, L C Boeije, et al.
Arthritis and Rheumatism|January 22, 2000
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosusM J Rood, M V van Krugten, E Zanelli, et al.
Arthritis and Rheumatism|November 11, 1999
Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritisM M Maurice, H Nakamura, S Gringhuis, et al.
Genes and Immunity|July 14, 2006
A subtype of multiple sclerosis defined by an activated immune defense programL G M van Baarsen, T C T M van der Pouw Kraan, J J Kragt, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsT C T M van der Pouw Kraan, C A Wijbrandts, L G M van Baarsen, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodiesP Miossec, C L Verweij, L Klareskog, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The Pharmacogenomics Journal|March 5, 2014
Gene expression analysis in RA: towards personalized medicineA N Burska, K Roget, M Blits, et al.
Genes and Immunity|November 9, 2002
Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphismT C T M van der Pouw Kraan, M Küçükaycan, A M Bakker, et al.
Molecular Medicine (Cambridge, Mass.)|February 5, 1999
Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritisE L Kaijzel, M V van Krugten, B M Brinkman, et al.
Genes and Immunity|October 12, 2007
Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patientsT C T M van der Pouw Kraan, L G M van Baarsen, C A Wijbrandts, et al.
Genes and Immunity|February 24, 2001
An IL-13 promoter polymorphism associated with increased risk of allergic asthmaT C van der Pouw Kraan, A van Veen, L C Boeije, et al.
Arthritis and Rheumatism|January 22, 2000
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosusM J Rood, M V van Krugten, E Zanelli, et al.
Arthritis and Rheumatism|November 11, 1999
Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritisM M Maurice, H Nakamura, S Gringhuis, et al.
Genes and Immunity|July 14, 2006
A subtype of multiple sclerosis defined by an activated immune defense programL G M van Baarsen, T C T M van der Pouw Kraan, J J Kragt, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsT C T M van der Pouw Kraan, C A Wijbrandts, L G M van Baarsen, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodiesP Miossec, C L Verweij, L Klareskog, et al.
Pageof 10